Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.36 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.36 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2814718 | 0.80 | TP53 (0.39) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 | |
| SCHEMBL2807377 | 0.80 | FFAR1 (0.39) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 | |
| SCHEMBL2806703 | 0.75 | KCNH2 (0.47) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 | |
| SCHEMBL4551400 | 0.69 | FFAR1 (0.44) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 | |
| SCHEMBL2811691 | 0.69 | TRPV4 (0.47) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 | |
| SCHEMBL8752132 | 0.65 | CYP1A2 (0.55) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 | |
| SCHEMBL11225320 | 0.65 | CYP1A2 (0.55) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 | |
| SCHEMBL21258034 | 0.65 | KCNH2 (0.47) | KCNH2GRM5HAO1 | |
| SCHEMBL4515748 | 0.64 | TRPV4 (0.39) | KCNH2CYP1A2GRM5 | |
| SCHEMBL31484811 | 0.62 | FFAR1 (0.38) | FFAR1FFAR4PDGFRBPDGFRAKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240908-A1 | ACETYLENE COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| EP-2202221-A1 | ACETYLENE COMPOUND | Fujifilm Corporation (JP) | 2010-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240908-A1 | ACETYLENE COMPOUND | NAT1, KATNA1, KAT2B | FFAR1 3015/4885FFAR4 4585/4885PDGFRB 3896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.